Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells

Iksoo Jeon, Nayeon Lee, Jia Yi Li, In Hyun Park, Kyoung Sun Park, Jisook Moon, Sung Han Shim, Chunggab Choi, Da Jeong Chang, Jihye Kwon, Seung Hun Oh, Dong Ah Shin, Hyun Sook Kim, Jeong Tae Do, Dong Ryul Lee, Manho Kim, Kyung Sun Kang, George Q. Daley, Patrik Brundin, Jihwan Song

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Induced pluripotent stem cells (iPSCs) generated from somatic cells of patients can be used to model different human diseases. They may also serve as sources of transplantable cells that can be used in novel cell therapies. Here, we analyzed neuronal properties of an iPSC line derived from a patient with a juvenile form of Huntington's disease (HD) carrying 72 CAG repeats (HD-iPSC). Although its initial neural inducing activity was lower than that of human embryonic stem cells, we found that HD-iPSC can give rise to GABAergic striatal neurons, the neuronal cell type that is most susceptible to degeneration in HD. We then transplanted HD-iPSC-derived neural precursors into a rat model of HD with a unilateral excitotoxic striatal lesion and observed a significant behavioral recovery in the grafted rats. Interestingly, during our in vitro culture and when the grafts were examined at 12 weeks after transplantation, no aggregate formation was detected. However, when the culture was treated with a proteasome inhibitor (MG132) or when the cells engrafted into neonatal brains were analyzed at 33 weeks, there were clear signs of HD pathology. Taken together, these results indicate that, although HD-iPSC carrying 72 CAG repeats can form GABAergic neurons and give rise to functional effects in vivo, without showing an overt HD phenotype, it is highly susceptible to proteasome inhibition and develops HD pathology at later stages of transplantation. These unique features of HD-iPSC will serve as useful tools to study HD pathology and develop novel therapeutics.

Original languageEnglish
Pages (from-to)2054-2062
Number of pages9
JournalStem Cells
Volume30
Issue number9
DOIs
Publication statusPublished - 2012 Sep 1

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Developmental Biology
  • Cell Biology

Cite this

Jeon, I., Lee, N., Li, J. Y., Park, I. H., Park, K. S., Moon, J., Shim, S. H., Choi, C., Chang, D. J., Kwon, J., Oh, S. H., Shin, D. A., Kim, H. S., Do, J. T., Lee, D. R., Kim, M., Kang, K. S., Daley, G. Q., Brundin, P., & Song, J. (2012). Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Stem Cells, 30(9), 2054-2062. https://doi.org/10.1002/stem.1135